Buspirone Hydrochloride Tablet
Product Images NDC 63187-904

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 63187-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

15 mg (the Entire Tablet) (Image 02)

FDA Label Image

10 mg (two-thirds Of A Tablet) (Image 03)

FDA Label Image

7.5 mg (one-half Of A Tablet) (Image 04)

FDA Label Image

5 mg (one-third Of A Tablet) (Image 05)

FDA Label Image

Break Tablet 15 mg (Image 06)

FDA Label Image

30 mg (the Entire Tablet) (Image 07)

FDA Label Image

20 mg (two-thirds Of A Tablet) (Image 08)

FDA Label Image

15 mg (one-half Of A Tablet) (Image 09)

FDA Label Image

10 mg (one-third Of A Tablet) (Image 10)

FDA Label Image

Break Tablet 30 mg (Image 11)

FDA Label Image

63187-904-90 (Image 13)

This is a description of a medicine called Buspirone HCI 10mg, manufactured by Pliva Hrvatska d.o.o., Zagreb, Croatia. Each bottle contains 30 round, beveled-edge, tablets of White to off-white color. The tablets are debossed “TEVA™ on one side and scored and debossed *54” on the other side. The NDC number of the medication is 63187-904-30, and its product ID is PB090430. The medicine should be stored between 20°C-25°C (68°F-77°F), and kept out of reach of children. It is sold in the USA by Proficent Rx LP, Thousand Oaks, CA 91320. The package contains Lot #00000 with an expiration date of 00/00/00.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.